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ABSTRACT    25 
Methylmercury-associated effects on the cardiovascular system have been documented 26 
though discrepancies exist, and most studied populations experience elevated methylmercury 27 
exposures.  No paper has investigated the impact of low-level elemental (inorganic) mercury 28 
exposure on cardiovascular risk in humans.  The purpose of this study was to increase 29 
understanding of the association between mercury exposure (methylmercury and elemental 30 
mercury) and blood pressure measures in a cohort of dental professionals that experience 31 
background exposures to both mercury forms. Dental professionals were recruited during the 32 
2010 Michigan Dental Association Annual Convention.  Mercury levels in hair and urine 33 
samples were analyzed as biomarkers of methylmercury and elemental mercury exposure, 34 
respectively.  Blood pressure (systolic, diastolic) was measured using an automated device. 35 
Distribution of mercury in hair (mean, range: 0.45, 0.02-5.18 μg/g) and urine (0.94, 0.03-5.54 36 
μg/L) correspond well with the US National Health and Nutrition Examination Survey.  Linear 37 
regression models revealed significant associations between diastolic blood pressure (adjusted 38 
for blood pressure medication use) and hair mercury (n=262, p=0.02). Urine mercury results 39 
opposed hair mercury in many ways.  Notably, elemental mercury exposure was associated with 40 
a significant systolic blood pressure decrease (n=262, p=0.04) that was driven by the male 41 
population. Associations between blood pressure and two forms of mercury were found at 42 
exposure levels relevant to the general population, and associations varied according to type of 43 
mercury exposure and gender.   44 
 45 





 Mercury is ranked a top three priority pollutant by the U.S. Environmental Protection 50 
Agency (EPA; US EPA, 1997) and the Centers for Disease Control (ATSDR, 2007).    The 51 
chemical speciation of mercury is complex and dictates its environmental fate, human exposure 52 
pathways, and toxic impacts (Clarkson and Magos, 2006).  The general population is largely 53 
exposed to methylmercury (MeHg+) through fish consumption and to elemental mercury (Hg0) 54 
through dental amalgams.  Approximately 6,600 tons of mercury is released into the atmosphere 55 
annually and concentrations continue to rise in many regions of the world (Swain et al., 2007).  56 
Accordingly, mercury will remain of public health concern for the foreseeable future. 57 
 58 
 Health concerns associated with methylmercury and elemental mercury exposure are 59 
primarily focused on the nervous system (Clarkson and Magos, 2006; US EPA, 1997).  60 
However, in recent years epidemiological studies have suggested a negative impact of 61 
methylmercury on the cardiovascular system.  Methylmercury exposure has been linked to acute 62 
myocardial infarction, and a  multi-disciplinary research committee deemed this evidence 63 
compelling to include this outcome in the regulatory risk assessment of mercury (Roman et al., 64 
2011). Though discrepancies exist, many studies have also found methylmercury-associated 65 
increases in diastolic (DBP) and systolic blood pressure (SBP).  In a study of 251 fish-consumers 66 
in the Brazilian Amazon, Fillion et al. (2006) found that participants with higher hair mercury, a 67 
biomarker for methylmercury exposure, had an increased risk of elevated SBP. In a study of 42 68 
male Faroese whalers, Choi et al. (2009) found a positive association between blood total 69 
1 Abbreviations: CRM (certified reference material); DBP (diastolic blood pressure); MDA (Michigan Dental 
Association); NHANES (National Health and Nutrition Examination Survey); SBP (systolic blood pressure) 
4 
                                                          
mercury levels, also reflective primarily of methylmercury exposure, and both SBP and DBP.  In 70 
another study from the Faroe Islands, Sørensen et al. (1999) found increased SBP and DBP in 7-71 
year-old children in relation to prenatal methylmercury exposure, though this association was not 72 
observed when children were re-evaluated at 14 years old (Grandjean et al., 2004). Likewise, 73 
Valera et al. (2009) found a positive association with blood mercury and SBP in an Inuit 74 
population.  From the 1999-2000 US National Health and Nutrition Examination Survey 75 
(NHANES), Vupputuri et al. (2005) found a negative association between blood total mercury 76 
and SBP, but only in women that did not consume fish. Dórea et al. (2005) did not observe 77 
positive associations between blood pressure and hair mercury levels in two Amazonian 78 
populations with heavy fish consumption.  79 
  80 
 The notion that methylmercury may be associated with increased risk of hypertension 81 
poses several health dilemmas.  Hypertension may affect one billion people worldwide 82 
(including 65 million in the US) and rates continue to rise (Egan et al., 2010; Lawes et al., 2008).  83 
Methylmercury is mainly derived from fish consumption, but fish are promoted as an excellent 84 
source of nutrients (e.g. omega-3 fatty acids) and protein.  Some scientific reviews have 85 
concluded that the heart-protective benefits of fish consumption outweigh health risks 86 
(Mozaffarian and Rimm, 2006), but when faced with the decision many consumers chose to 87 
avoid consuming fish (Oken et al., 2003).   88 
 89 
 In addition to methylmercury exposure, the general public is exposed to elemental 90 
mercury largely through dental amalgams.  Though several animal studies have documented that 91 
elemental mercury may decrease myocardial mechanical activity, depress heart rate, promote 92 
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heart arrhythmias, and cause hypotension (Massaroni et al., 1995; Rhee and Choi, 1989; Rossoni 93 
et al., 1999), to our knowledge these relationships have not been investigated in an 94 
epidemiological study.  Accordingly, the goal of this study was to increase understanding of the 95 
association between mercury exposure (both methylmercury and elemental mercury) and blood 96 
pressure in a cohort of dental professionals.  This work extends upon previous studies that 97 
focused solely on methylmercury exposure by also considering exposures to elemental mercury.  98 
Further, mercury exposures in this study are more relevant to the general population than the 99 
aforementioned studies focused on susceptible groups (e.g., indigenous peoples, fish-consumers) 100 
with moderate to high methylmercury intakes.    101 
102 
6 
MATERIALS AND METHODS 103 
 104 
Study Population  105 
 A convenience sample of 284 dental professionals (dentists, hygienists, dental assistants) 106 
was recruited during the 2010 Michigan Dental Association (MDA) Annual Convention as part 107 
of a larger cohort designed to study the influence of genetic variability on mercury body burden 108 
(Goodrich et al., 2011; Wang et al., 2012).  Institutional Review Board (IRB) approval for this 109 
work was obtained from the University of Michigan (HUM00027621).  A self-administered 110 
survey was used to collect information on demographics (e.g., age, height), occupational 111 
practices, medical history, and alcohol consumption. Subjects also provided detailed information 112 
on fish consumption patterns (e.g., portion size, frequency of consumption of 28 fish species) 113 
which was used to calculate a mercury intake value (μg mercury/kg body weight/day) as 114 
described previously (Wang et al., 2012) based on the most recent mercury levels measured in 115 
common fish species in the US (Bahnick et al., 1994; Mierzykowski et al., 2001; US FDA). 116 
Total polyunsaturated fatty acid (PUFA; mg/kg body weight/day) and selenium (μg/kg body 117 
weight/day) intake values from species-specific fish consumption were also calculated using the 118 
US Department of Agriculture Nutrient Database. Subjects reported the number of mercury-119 
containing dental amalgams in their own mouths along with the average number per week that 120 
they remove and place in their dental practice (amalgams handled). Subjects with missing data 121 
points (e.g. urine mercury, SBP, age) were excluded. Four additional subjects reporting kidney 122 
disease were excluded due to the potential effects on mercury excretion, resulting in a sample 123 
size of 262.  124 
 125 
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Mercury Exposure Assessment 126 
 Urine is used to assess elemental mercury exposure and hair is used to assess 127 
methylmercury exposure (Berglund et al., 2005; Clarkson and Magos, 2006).  From each 128 
participant, spot urine samples (~30-50mL) were collected and stored frozen.  Hair was collected 129 
by cutting 20-50 strands from the occipital region of the head as close to the scalp as possible, 130 
wrapping in paper, and then storing at room temperature. 131 
  132 
Total mercury levels were measured using a direct mercury analyzer (DMA-80, 133 
Milestone Inc., CT) according to US EPA Method 7473.  Briefly, 800 μL of urine or 4-9 mg of 134 
hair from the two cm closest to the scalp were analyzed according to methods we have 135 
previously described (Basu et al., 2010; Goodrich et al., 2011; Paruchuri et al., 2010).  In every 136 
batch of 10-15 samples, one blank, one replicate sample, and a certified reference material (hair: 137 
NIES Japan CRM #13; urine: Institut National de Sante Publique Quebec standard 138 
QMEQAS08U-01; dogfish liver: DOLT4, National Research Council Canada) were included. 139 
Specific gravity was measured using a refractometer (PAL-10S, Atago U.S.A., Inc., WA). Urine 140 
mercury levels were adjusted to reflect the average specific gravity in all samples (1.017) 141 
according to the method of Levine and Fahy (1945) as this has been shown to reduce variability 142 
in metal analysis of spot urine samples (Lee et al., 1996; Mason and Calder, 1994).  All final 143 
values reported here are unadjusted.    144 
 145 
 The average theoretical method detection limit (3x standard deviation of blanks) was 146 
0.003 µg/g mercury for hair and 0.014 µg/L mercury for urine.  The average recovery of mercury 147 
was 88.9±1.1% for the hair CRM, 71.5±3.9% for the mean urine CRM value, and 91.8±6.6% for 148 
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DOLT4.  The mercury value in the urine CRM has a range of expected values, and our percent 149 
recovery was judged according to the reported mean.  Machine accuracy is deemed high given 150 
that recovery of other reference materials (e.g., DOLT4) measured alongside the urine CRM had 151 
excellent recovery (>90%). Within-day (0.7% for hair, 4.2% for urine, 2.8% for DOLT4) and 152 
between day (1.0% for hair, 5.4% for urine, 6.1% for DOLT4) variability of CRMs were 153 
calculated, and these values corresponded well to replicate analysis of actual samples provided 154 
by participants (data not shown).   155 
 156 
Blood Pressure and Pulse Assessment 157 
 Participants were seated for at least five minutes before blood pressure was measured.  A 158 
commercially available blood pressure device (Omron HEM 432-C) was placed over the right 159 
brachial artery and used to measure SBP, DBP, and pulse. From each participant, three readings 160 
were averaged. Variability within replicates of individuals averaged 4.2% (SBP), 4.8% (DBP), 161 
and 3.3% (pulse).  162 
 163 
Statistical Analyses 164 
 All statistical operations were performed using PASW® Statistics Software (v. 18; 165 
Chicago, IL).  Preliminary data analysis included tabulation of descriptive statistics for all 166 
measurements. Bivariate (Pearson correlations) and multivariate analyses were performed to 167 
identify factors that influenced SBP and DBP. Blood pressure measurements of individuals using 168 
hypertension controlling medications were imputed 15 mmHg higher (SBP) and 10 mmHg 169 
higher (DBP) before linear regression as this has been shown to reduce bias and improve 170 
statistical power (Tobin et al., 2005). All bivariate and multivariate analyses were performed 171 
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with adjusted and unadjusted SBP and DBP; analyses with the latter excluded subjects using 172 
anti-hypertensive medication (n=39).  173 
 174 
The backward elimination method was used to determine predictors of SBP and DBP 175 
(adjusted for medication use) with an initial cut-off significance value of p>0.10. Variables 176 
considered in the multivariate models were age, BMI, gender, race, occupation (dentist vs. non-177 
dentist), alcohol (drinks/day), fish nutrients/toxicants (PUFA, selenium, mercury), personal 178 
amalgams, and occupational exposures (hours worked/week, categorical variable for number of 179 
amalgams handled/week). The final model for SBP included the only significant predictors 180 
(p<0.05): BMI, age, and gender. Significant predictors of DBP were BMI and age, though 181 
gender was also included in the final model to control for gender differences observed in our 182 
population. Hair and urine mercury (together and in separate models, with unadjusted or specific 183 
gravity adjusted urine mercury) were added into SBP and DBP base models to assess the 184 
association between mercury biomarkers and blood pressure after controlling for confounders. 185 
Multivariable linear regression models were run for the total population and for subgroups 186 
(males, females, dentists, non-dentists). Potentially influential subjects were identified using 187 
statistical diagnostics (e.g. Cook’s distance, dfbeta) on total population models, and removed 188 
individually to assess the impact of the subject on the relationships between mercury biomarkers 189 
and blood pressure.       190 
 191 
 192 
  193 
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RESULTS 194 
  195 
 Table 1 outlines demographics, cardiovascular parameters, and major sources of mercury 196 
exposure in study participants, and is stratified according to gender, occupation (dentists versus 197 
non-dentists), and anti-hypertensive medication usage. Of all participants, 38% were males and 198 
44% were dentists. Overall, males were significantly older, had greater BMIs and alcohol 199 
consumption compared with females while also having higher blood pressure and lower pulse. 200 
Dentists, of which 80% are males, likewise had similar differences compared to non-dentists 201 
(dental hygienists, dental assistants and other professionals, of whom 94% were female). A 202 
significantly larger proportion of individuals taking blood pressure medication were males and 203 
dentists (χ2 test, p-value <0.05, data not shown). The influence of race-ethnicity on blood 204 
pressure could not be adequately assessed in this population as 92% of the subjects identified as 205 
non-Hispanic and Caucasian.  206 
  207 
 Table 2 reports total mercury levels in hair and urine. In this population, estimated 208 
mercury intake from fish consumption was the best predictor of hair mercury levels in linear 209 
regression modeling, though personal dental amalgams contributed to a lesser extent. Occupation 210 
and amalgams (personal and handled in the dental practice) were the predictors of urine mercury 211 
levels (data not shown) indicating hair and urine as biomarkers of primarily methylmercury and 212 
elemental mercury, respectively, as others have previously established (Berglund et al., 2005; 213 
Clarkson and Magos, 2006). All subjects had mercury levels above the method detection limit. 214 
Mean hair mercury (± standard deviation) was 0.45±0.53 μg/g (range: 0.02-5.18) and mean urine 215 
mercury was 0.94±0.99 μg/L (range: 0.03-5.54). While median hair and urine mercury values 216 
were 47% and 31% higher than U.S. population medians reported by NHANES (CDC, 2009; 217 
11 
McDowell et al., 2004), there is considerable overlap of the distributions for both biomarkers 218 
between the dental cohort and NHANES (Table 2). Mean hair and urine mercury levels were 219 
significantly higher in males and dentists, the latter of which correspond with greater 220 
occupational exposure to amalgams (ANOVA p<0.05).   221 
  222 
 Seventy-three participants (28% of study population) displayed hypertension (SBP ≥ 140 223 
mmHg and/or DBP ≥ 90 mmHg as defined by the U.S. Department of Health and Human 224 
Services, 2004) and/or were using blood pressure medication at the time of measurement. Blood 225 
pressure measurements performed by us were in the hypertension range for 47 individuals 226 
(18%). Several significant correlations were found between hair mercury levels and blood 227 
pressure outcomes (p<0.05).  Bivariate analyses estimated that SBP and DBP (adjusted for anti-228 
hypertensive medication use) were significantly correlated with hair mercury levels (r=0.22, 229 
0.19, respectively). There were no significant bivariate correlations between urine mercury and 230 
adjusted SBP (r=0.05) or DBP (r=0.06). BMI and age were significantly positively correlated 231 
with adjusted SBP (r=0.33, 0.58, respectively) and DBP (0.38, 0.31). Hair and urine biomarker 232 
measurements were also significantly correlated with one another (r=0.29).  233 
 234 
  Multivariate linear regression modeling of SBP and DBP was used to assess associations 235 
with urine or hair mercury levels after adjusting for BMI, age, and gender. Parameter estimates 236 
for total, gender stratified, and dentist-only populations in models of SBP and DBP (values first 237 
adjusted for hypertension-controlling medication use according to the method of Tobin et al., 238 
2005 and referred to as “adjusted SBP/DBP”) are reported in Table 3. In the majority of models, 239 
BMI, age, and gender were significant predictors of these outcomes. There was a trend towards 240 
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positive association with hair mercury and SBP and DBP in all models, though this association 241 
was only significant when modeling adjusted DBP (β=2.76 mmHg DBP increase per 1 μg/g Hg 242 
in hair, p=0.02. Further, the parameter estimates were consistently larger in males versus 243 
females. While a significant association was observed between hair mercury and DBP in the 244 
male-only model (β=2.94 mmHg, p=0.03), this model did not capture most of the variability in 245 
DBP among males (adjusted r2=0.06). Results should be interpreted with caution. Alcohol 246 
consumption (drinks/day) and dental amalgams were near significant predictors (p<0.10) of 247 
adjusted DBP. However, inclusion of these parameters in the DBP model did not change 248 
parameter estimates (significance, magnitude) of mercury biomarkers (data not shown).  249 
 250 
The urine mercury and blood pressure relationship differed from hair mercury results. 251 
Urine mercury levels were associated with decreased SBP (in total population model: β= -1.8 252 
mmHg SBP per 1 μg/L Hg in urine), though this was only significant in models adjusting for 253 
anti-hypertensive medication use and appeared to be driven by the males and the dentists. Urine 254 
mercury was not associated with DBP, though negative trends were also observed among males 255 
and dentists. Even though several model parameters were significantly correlated with one 256 
another (e.g. BMI and age, hair and urine mercury), multicollinearity is not expected to be 257 
problematic as variance inflation factors were less than 1.5 for all aforementioned regression 258 
models.   259 
 260 
The significance levels of parameter estimates for mercury biomarkers in blood pressure 261 
models were sensitive to several influential subjects discovered via standard diagnostic tests. The 262 
exclusion of one subject partially diminished the association between hair mercury and adjusted 263 
13 
DBP (β=2.29 mmHg, p=0.07).  The magnitude and significance of the association between urine 264 
mercury and decreased SBP were slightly diminished when excluding several influential 265 
subjects, most of whom had urine mercury levels above the 95th percentile (0.06<p<0.13 for new 266 
parameter estimates). Adjusting urine mercury for specific gravity altered its significance in the 267 
total population model of SBP (β= -1.75 mmHg, p=0.13) and the r-square of the model (adj r2= 268 
0.421, 1% decrease). Specific gravity-adjusted urine mercury remained significant in models of 269 




There are a growing number of studies documenting an association between 273 
methylmercury exposure and elevated blood pressure but discrepancies exist.  Despite the fact 274 
that our cohort was not initially designed to study cardiovascular effects of mercury exposure 275 
and lacks information on one important confounder- smoking status, our study contributes to 276 
data on mercury exposure and blood pressure in several ways. Here we report that exposures 277 
relevant to the general population to both elemental mercury and methylmercury may be 278 
associated with altered blood pressure measures, though the significance of these results is 279 
partially dependent on several subjects with higher exposure (>95th percentile).  Interestingly, 280 
divergent blood pressure results were found for mercury type and may be influenced by gender.  281 
Hair mercury levels were associated with increased DBP (after adjustment for anti-hypertensive 282 
medication use according to the method of Tobin et al., 2005).  For urine mercury, the results 283 
from linear regression models suggest that elemental mercury exposure is associated with 284 
decreased SBP in the total population, and this appears to be driven by the male subgroup. While 285 
Kobal et al. (2004) previously found an association between extremely high past exposures to 286 
elemental mercury (>800 μg/L urinary mercury) and increased SBP, to our knowledge this is the 287 
first human study to investigate elemental mercury exposures relevant to the general population 288 
in relation to blood pressure. 289 
  290 
Previous studies have reported an association between methylmercury exposure and 291 
increased blood pressure (Choi et al., 2009; Fillion et al., 2006; Sørensen et al., 1999; Valera et 292 
al., 2009) but these have largely been conducted in populations of subsistence fish consumers 293 
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that experience moderate to high methylmercury exposures. Here, we find a similar trend 294 
between elevated blood pressure and hair mercury levels in a population that is exposed to 295 
methylmercury at concentrations that better reflect exposures of the general US population 296 
(McDowell et al., 2004) and other countries (Díez et al., 2008; Gundacker et al., 2007). As 297 
expected, the male gender, age, and BMI were significant predictors of increased SBP. Likewise, 298 
age and BMI predicted DBP in multivariate linear regression, factors which are often associated 299 
with increased risk for hypertension (Greenlund et al., 2009; Kim et al., 2007).  In addition, we 300 
found a trend towards a methylmercury exposure dependent increase in SBP and DBP across all 301 
sub-groups in our study (e.g., males, females, dentists, excluding medication users), though this 302 
relationship only attained statistical significance in models of adjusted DBP and was partially 303 
dependent on one influential subject.  304 
 305 
 The prevalence of hypertension in our study population (28% of total had SBP ≥ 140 306 
mmHg, DBP ≥ 90 mmHg, and/or reported using anti-hypertensive medication) is similar to the 307 
U.S. average of 28.9% which continues to increase (Cutler et al., 2008). The fact that we found a 308 
weak association between “background” methylmercury exposure and increased DBP within this 309 
cohort suggests that the threshold of effect may be low, if a threshold exists, and the burden of 310 
impact could be greater in populations with higher methylmercury exposure (e.g., subsistence 311 
fish eating populations).  These findings are of public health concern given that nearly 30% of 312 
adults in the U.S. and ~ 1 billion worldwide may suffer from hypertension, and that elevated 313 
blood pressure accounts for 54% of strokes, 47% of heart disease, and 14% of all deaths (Lawes 314 
et al., 2008). 315 
 316 
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 This is the first study, to our knowledge, to directly assess the relationship between 317 
relevant elemental mercury exposure and blood pressure outcomes in a human population that 318 
experiences background exposures.  Dental amalgams typically consist of 50% mercury by 319 
weight (Clarkson and Magos, 2006).  Accordingly, urine mercury levels among dental 320 
practitioners are strongly predicted by the number of amalgams they remove or place (Martin et 321 
al., 1995).  In the 1970s and 1980s, urine mercury levels in dentists regularly exceeded 10 µg/L 322 
but values have dropped significantly in recent years owing to educational campaigns and a shift 323 
towards composite resin fillings (Eklund, 2010; Shapiro et al., 1982).  This decrease is supported 324 
by the current study where urine biomarkers of elemental mercury exposure among dental 325 
professionals in Michigan mirrored the general US population (CDC, 2009; Table 2), suggesting 326 
that our findings may have broad relevance to public health.  Despite low-level elemental 327 
mercury exposure (maximum=5.5 µg/L), associations with SBP were found.   Unlike the hair 328 
mercury associations, a urine mercury-associated decrease in adjusted SBP was observed in the 329 
total population and was driven by the males and dentists. The significance of this association 330 
was influenced by several subjects with higher urine mercury levels, and as such this relationship 331 
should be further explored in a population with a wider range of exposure (maximum >10 µg/L). 332 
These findings suggest that levels of urine mercury found in the general adult US population, 333 
which average 20-100 times less than exposure limits set by the World Health Organization (50 334 
µg/L), may be associated with alterations in blood pressure and that these may be gender-335 
specific. While elemental mercury exposures of the general population are low, certain groups 336 
still remain at great risk of elemental mercury exposure, such as small-scale gold miners 337 
(Paruchuri et al., 2010).   338 
 339 
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 For hair and urine mercury, gender influenced the observed trends.  At this moment it is 340 
not clear why elemental mercury-associated decreases in SBP are observed in males only, or 341 
why methylmercury-associated increases in blood pressure are stronger in males, though 342 
increasing toxicological and epidemiological studies are stressing the importance of considering 343 
gender-specific differences in chemical exposures, toxicokinetics, and health impacts (Institute 344 
of Medicine, 2001; Vahter et al., 2007).  Experimental rodent studies have documented gender 345 
differences in the distribution, metabolism, and elimination of methylmercury and inorganic 346 
mercury (Ekstrand et al., 2010; Thomas et al., 1986, 1987).  With respect to hypertension, 347 
gender-specific differences have been reported in women in terms of age-related onset and metal 348 
sensitivity (Reckelhoff, 2001; Vahter et al., 2007). The differences observed in this study may 349 
reflect true gender differences in the relationship between mercury and blood pressure, or they 350 
may have resulted from random variation due to small sample sizes.  351 
 352 
 In addition to disparate gender results, elemental mercury results differed from the 353 
methylmercury results in many cases. The effect of elemental mercury on cardiovascular 354 
function in humans is not well characterized, but there are laboratory animal studies that may 355 
shed light on our findings. The general trends observed in our elemental mercury-exposed male 356 
population are consistent with animal studies that have reported that high doses of inorganic 357 
mercury cause depressed arterial systolic pressure (Massaroni et al., 1995; Rhee and Choi, 1989; 358 
Rossoni et al., 1999).  Differences between elemental mercury and methylmercury effects may 359 
be realized at the cellular level.  One purported mechanism by which mercury affects blood 360 
pressure is through disruption of calcium homeostasis, and there are reported differences among 361 
methylmercury and elemental mercury in terms of potency, sensitivity towards certain calcium 362 
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channel subtypes, the nature of inhibition, and alteration of channel function (Atchinson, 2003; 363 
Sakamoto et al., 1996). Evidence in animals and humans suggests that methylmercury-induced 364 
oxidative stress can inhibit production of nitric oxide, a vasodilator, and lead to vascular 365 
endothelial dysfunction, mechanisms related to hypertension (Dharmashankar and Widlansky, 366 
2010; de Marco et al., 2009; Grotto et al., 2009; Mazerik et al., 2007). Several differential 367 
mechanisms may underlie the opposite association observed between elemental mercury and 368 
SBP.  Massaroni et al. (1995) found mercuric chloride increased autonomic neurotransmitter 369 
release in rats experiencing hypotension following treatment. Inorganic mercury may 370 
furthermore impact blood pressure indirectly via interaction with the kidney, an organ 371 
specifically targeted by inorganic species of mercury (Clarkson and Magos, 2006). Mercurial 372 
drugs such as calomel inhibit sodium and chloride reabsorption in the kidney and were formerly 373 
prescribed as diuretics and anti-hypertensive medication until the mid-1900s (Norn et al., 2008; 374 
Wolf et al., 1966). Interactions between elemental mercury, kidneys and decreased SBP merit 375 
further exploration.  376 
 377 
 Even though this study had several limitations, associations were found between low-378 
level mercury exposures and blood pressure alterations. Associations and trends observed here 379 
corroborate several epidemiological (for methylmercury) and animal (for elemental mercury) 380 
studies, and thus minimize concern of chance-related significant outcomes stemming from 381 
multiple statistical tests.  While subjects did not know their urine or hair mercury levels before 382 
participating in the study, dental professionals are cognizant of mercury as a public health issue 383 
and likely were aware of occupational exposures and possibly environmental exposures they may 384 
have experienced.  Since we observed mercury distributions that overlapped with biomarker 385 
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levels measured in NHANES participants, it is possible that dental professionals with lower than 386 
average occupational exposures self-selected to volunteer for this study. . If this negative 387 
selection bias did occur, it is not expected to significantly impact the results reported here as we 388 
were still able to explore relationships between a range of mercury biomarker levels, and 389 
SBP/DBP. Due to the cross-sectional design, we were unable to assess the impact of past 390 
exposures or lifestyle changes on blood pressure. Gender stratification was performed on all 391 
analyses due to the age, BMI, mercury exposure and occupational differences observed between 392 
our male and female participants, but this may have limited our power due to smaller sample 393 
size. Significant associations between hair mercury and DBP and urine mercury and SBP were 394 
still observed in the male population even with the decreased statistical power.  395 
 396 
Our analyses did not include one major potential confounder- smoking status- as this 397 
information was not collected from our subjects. While smoking is often considered a risk factor 398 
for hypertension and has been shown to influence cadmium and lead biomarker levels, smoking 399 
has not been shown to affect mercury biomarker levels in most studies (Dewailly et al., 2001; 400 
Levy et al., 2007), with exceptions (Freire et al., 2010). Another limitation of this study may be 401 
the lack of mercury speciation in biomarker samples. While hair and urine are typically deemed 402 
biomarkers of methylmercury and inorganic mercury exposure, respectively, (Berglund et al., 403 
2005), evidence in occupational cohorts with exposure to elemental mercury suggests that a 404 
fraction of hair mercury may reflect inorganic mercury exposure (Morton et al., 2004; Wranová 405 
et al., 2008). In the MDA cohort, amalgams were weakly associated with hair mercury even 406 
though fish consumption was the main predictor. However, mercury speciation of the MDA 407 
biomarker samples would be predicted to increase the significance of the relationships observed 408 
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(elemental mercury with decreased SBP and methylmercury with increased DBP) if the two 409 
mercury forms truly have opposing associations with blood pressure.      410 
 411 
This study reports significant, albeit borderline significant (0.01<p<0.05) and partially 412 
outlier influenced, associations between elevated DBP and hair mercury and between decreased 413 
SBP and urine mercury at exposure levels relevant to the general population.  Even though these 414 
differential relationships were observed in face of many study limitations, comparable significant 415 
associations were observed (blood mercury with increased DBP, p<0.05, and urine mercury with 416 
decreased SBP, p<0.0001) using NHANES data (n>4,000) after controlling for seven 417 
confounders including smoking status and race (data not published).  As such, future work on 418 
mercury and cardiovascular health should consider both elemental mercury and methylmercury 419 
at wide ranges of exposure in males and females to gain a better understanding of how these 420 
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Gender Occupation Blood Pressure Medication 
 Males Females Dentists Non-
Dentists 
No Yes 
n 262 99 163 114 148 223 39 
BMI 
(kg/m2) 



















124 (15.3) 133 (13.3) 119 (14.1)e 130 (15.2) 120 (13.9)e 123 (14.6) 135 (15.1)e 
DBP 
(mm Hg) 
73.5 (9.3) 75.9 (8.2) 72.0 (9.7)d 75.0 (8.7) 72.3 (9.7)c 72.9 (9.2) 76.8 (9.6)c 
Pulse 
(beats/min) 
72.7 (11.8) 69.1 (12.9) 74.9 (10.5)e 69.8 (12.6) 75.0 (10.6)e 73.3 (11.5) 69.4 (13.1) 
 Alcohol  
(drinks/day) 
0.42 (0.55) 0.54 (0.65) 0.34 (0.47)d 0.55 (0.66) 0.31 (0.43)d 0.38 (0.52) 0.64 (0.65)d 
Amalgama 
 
3.58 (3.42) 4.01 (3.44) 3.33 (3.39) 4.15 (3.59) 3.15 (3.24)c 3.25 (3.12) 5.49 (4.40)e 
Amalgams 
handleda 
27.9 (47.3) 43.6 (57.1) 18.4 (37.4)e 48.0 (57.1) 12.4 (30.2)e 26.9 (46.9) 33.2 (50.0) 
Hg intakeb  
(μg/kg bw/day) 
0.08 (0.12) 0.09 (0.13) 0.07 (0.12) 0.09 (0.13) 0.07 (0.12) 0.07 (0.12) 0.10 (0.14) 
        
aAmalgam is the number of mercury-containing dental amalgams in the subject’s mouth while amalgams handled is the sum of dental 
amalgams removed and placed per week in occupational practice. 
bHg intake estimated from reported fish consumption (type, portion size, consumption frequency).  
 c p<0.05, ANOVA tests comparing paired categories (male vs. female, dentists vs. non-dentists, blood pressure medication users vs. 
non-users) 
d p<0.01  
e p<0.001  
 
  
Table 2. Mercury biomarker levels in total and stratified population.   
 
aNHANES- National Health and Nutrition Examination Survey.  Urine data from CDC 2009; hair data from McDowell et al. 2004.  
b p<0.01 and c p<0.001 for ANOVA comparing natural log-transformed values for paired categories (male vs. female, dentists vs. non-
dentists, BP medication users vs. non-users).   
  n Mean St dev 25th % 50th % 75th % 90th % 95th % 
HAIR MERCURY (μg/g)         
 Total 262 0.45 0.53 0.14 0.28 0.55 1.06 1.31 
 NHANESa 1726 0.47  0.09 0.19 0.42 1.11 1.73 
Gender Males 99 0.65 0.71 0.24 0.50 0.83 1.33 1.43 
 Females 163 0.33c 0.34 0.11 0.21 0.43 0.82 1.06 
Occupation Dentists 114 0.64 0.69 0.25 0.48 0.83 1.31 1.69 
 Non-Dentists 148 0.30c 0.29 0.11 0.19 0.39 0.72 1.00 
Medication No BP Meds 223 0.41 0.51 0.13 0.26 0.51 0.95 1.31 
 BP Meds 39 0.66b 0.63 0.21 0.56 0.90 1.22 1.39 
URINE MERCURY (μg/L)         
 Total  262 0.94 0.99 0.31 0.63 1.18 2.09 2.76 
 NHANESa 1529    0.48 1.12 2.20 3.33 
Gender Males 99 1.27 1.22 0.51 0.85 1.50 2.66 4.87 
 Females 163 0.74c 0.75 0.26 0.47 0.98 1.76 2.20 
Occupation Dentists 114 1.26 1.19 0.49 0.85 1.53 2.56 4.47 
 Non-Dentists 148 0.69c 0.70 0.25 0.44 0.92 1.61 2.00 
Medication No BP Meds 223 0.93 1.02 0.29 0.60 1.13 1.94 3.54 
 BP Meds 39 1.01 0.79 0.38 0.66 1.60 2.35 2.46 
Table 3. Parameter estimates for linear regression models (with p-values in parentheses below the β estimates). Blood pressure 
measurements of individuals using hypertension controlling medications were imputed 15 mmHg higher (SBP) and 10 mmHg higher 
(DBP) according to the method of Tobin et al. (2005). 
Dependent 
Variable 
Population n Adj. R2 BMI Age Female Hair Hg Urine Hg 
SBP 
(mmHg) 
Total 262 0.43 0.97 0.67 -5.74 2.67 -1.80 
   (<0.001) (<0.001) (0.005) (0.11) (0.04) 
Males 99 0.24 1.17 0.59  3.15 -3.26 
   (0.004) (<0.001)  (0.13) (0.009) 
Females 163 0.35 0.86 0.74  1.54 0.71 
   (<0.001) (<0.001)  (0.63) (0.60) 
Dentists  114 0.44 1.15 0.72 -7.89 2.07 -3.35 
   (0.001) (<0.001) (0.03) (0.27) (0.003) 
        
DBP 
(mmHg) 
Total 262 0.22 0.83 0.18 -1.26 2.76 -0.32 
   (<0.001) (0.002) (0.37) (0.02) (0.61) 
Males 99 0.06 0.54 0.05  2.94 -1.13 
   (0.04) (0.59)  (0.03) (0.16) 
Females 163 0.26 0.89 0.27  1.87 1.10 
    (<0.001) (<0.001)  (0.42) (0.26) 
 Dentists 114 0.15 0.71 0.12 -3.31 2.11 -0.88 
    (0.003) (0.16) (0.17) (0.10) (0.25) 
 
  
